Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Int.biotech. (IBT) Share Price

Price 1,025.00p on 18-11-2026 at 05:12:23
Change 0.00p 0%
Buy 1,040.00p
Sell 1,025.00p
Last Trade: Sell 252.00 at 1,025.00p
Day's Volume: 0
Last Close: 1,025.00p
Open: 0.00p
ISIN: GB0004559349
Day's Range 0.00p - 0.00p
52wk Range: 842.00p - 1,215.00p
Market Capitalisation: £324.44m
VWAP: 0.00p
Shares in Issue: 31.65m

Int.biotech. (IBT) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 252 1,025.00p Uncrossing Trade
16:35:14 - 17-Nov-26
Sell* 176 1,034.0966p Ordinary
16:26:11 - 17-Nov-26
Buy* 2 1,038.607p Suspected BUY Trade
16:25:30 - 17-Nov-26
Sell* 1,384 1,034.0604p Ordinary
16:22:46 - 17-Nov-26
Sell* 1,071 1,034.0503p Ordinary
16:21:39 - 17-Nov-26
Buy* 1,000 1,039.99p Ordinary
16:14:46 - 17-Nov-26
Sell* 1,266 1,034.0303p Ordinary
16:11:12 - 17-Nov-26
Buy* 100 1,037.80p Ordinary
16:10:18 - 17-Nov-26
Sell* 500 1,034.02p Ordinary
16:08:31 - 17-Nov-26
Buy* 288 1,035.00p Automatic Execution
16:04:26 - 17-Nov-26
See more Int.biotech. trades

Int.biotech. (IBT) Share Price History

Time period:
to
Date Open High Low Close Volume
18th Nov 2026 (Wed) 1,025.00 1,025.00 1,025.00 1,025.00 0
17th Nov 2026 (Tue) 1,060.00 1,060.00 1,025.00 1,025.00 37,395
16th Nov 2026 (Mon) 1,085.00 1,090.00 1,065.00 1,065.00 71,184
13th Nov 2026 (Fri) 1,080.00 1,095.00 1,065.00 1,065.00 30,915
12th Nov 2026 (Thu) 1,085.00 1,120.00 1,085.00 1,110.00 131,224
11th Nov 2026 (Wed) 1,075.00 1,115.00 1,075.00 1,115.00 68,394
10th Nov 2026 (Tue) 1,075.00 1,090.00 1,072.50 1,080.00 29,667
9th Nov 2026 (Mon) 1,050.00 1,070.00 1,050.00 1,070.00 62,065
6th Nov 2026 (Fri) 1,035.00 1,050.00 1,030.00 1,050.00 70,671
5th Nov 2026 (Thu) 1,050.00 1,080.00 1,045.00 1,055.00 147,395
4th Nov 2026 (Wed) 1,040.00 1,050.00 1,030.00 1,045.00 62,542
3rd Nov 2026 (Tue) 1,025.00 1,045.00 1,020.00 1,035.00 34,741
2nd Nov 2026 (Mon) 1,040.00 1,045.00 1,035.00 1,035.00 49,965
30th Oct 2026 (Fri) 1,045.00 1,060.00 1,040.00 1,040.00 109,449
29th Oct 2026 (Thu) 1,050.00 1,060.00 1,040.00 1,040.00 56,055
28th Oct 2026 (Wed) 1,025.00 1,045.00 1,025.00 1,045.00 18,492
27th Oct 2026 (Tue) 1,015.00 1,025.00 1,015.00 1,020.00 175,685
26th Oct 2026 (Mon) 1,035.00 1,035.00 1,015.00 1,015.00 36,552
23rd Oct 2026 (Fri) 1,065.00 1,065.00 1,015.00 1,025.00 27,460
22nd Oct 2026 (Thu) 1,045.00 1,050.00 1,030.00 1,040.00 36,553
21st Oct 2026 (Wed) 1,040.00 1,050.00 1,020.00 1,050.00 64,118
20th Oct 2026 (Tue) 1,010.00 1,040.00 1,005.00 1,040.00 50,269
19th Oct 2026 (Mon) 1,000.00 1,010.00 982.00 1,010.00 101,125
See more Int.biotech. price history

Int.biotech. (IBT) Regulatory News

Date Source Headline
17th Nov 2026 11:22 am RNS Net Asset Value(s)
16th Nov 2026 11:23 am RNS Net Asset Value(s)
13th Nov 2026 11:35 am RNS Net Asset Value(s)
12th Nov 2026 11:00 am RNS Net Asset Value(s)
11th Nov 2026 11:15 am RNS Net Asset Value(s)
10th Nov 2026 11:53 am RNS Net Asset Value(s)
9th Nov 2026 11:44 am RNS Net Asset Value(s)
6th Nov 2026 11:44 am RNS Net Asset Value(s)
6th Nov 2026 7:00 am RNS-R Kepler Trust Intelligence: New Research
5th Nov 2026 11:36 am RNS Net Asset Value(s)
See more Int.biotech. regulatory news

Int.biotech. (IBT) Share News

EARNINGS: Focusrite doubles interim profit; PACSCo back on AIM

3rd Nov 2026 14:24

(Alliance News) - The following is a round-up of earnings of London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

UK dividends calendar - next 7 days

14th Aug 2026 12:57

Read More

UK dividends calendar - next 7 days

16th Jul 2026 14:44

Read More

IBT company Crinetics to be acquired by Vertex for USD10 billion

7th Jul 2026 19:11

(Alliance News) - International Biotechnology Trust PLC on Tuesday said its portfolio company, Crinetics Pharmaceuticals Inc, entered a deal to be acquired by Vertex Pharmaceuticals Inc in a deal worth USD10 billion. Read More

IN BRIEF: International Biotech highlights deal for investee Apogee

22nd Jun 2026 20:07

International Biotechnology Trust PLC - invests in biotechnology companies - Notes announcement that investee company Apogee Therapeutics is to be acquired by AbbVie Inc. Apogee shareholders will receive USD135.11 per share in cash at closing. As at close of business on Friday, Apogee represented around 0.41% of IBT's net asset value. IBT Portfolio Managers Ailsa Craig and Marek Poszepczynski say: "The biotech M&A boom shows no signs of slowing, with deal flow running ahead of last year's pace. The latest deal represents the seventh acquisition within the IBT portfolio in 2026 so far, compared to three acquisitions at the same stage last year, with the total value of the companies acquired also up 9%. This demonstrates the success of our investment strategy." Read More

See more Int.biotech. news
FTSE 100 Latest
Value10,689.87
Change-191.68

Login to your account

Forgot Password?

Not Registered